Breastcancer.org Podcast

335 Episodes

1. Enhertu for HER2-Low Breast Cancer

   Published: 08/07/2022
2. Loosening COVID-19 Restrictions and Immunocompromised People: Do You Feel Left Behind?

   Published: 24/06/2022
3. Genetic and Genomic Tests: What’s the Difference?

   Published: 02/06/2022
4. Just Ask: Increasing Diversity in Clinical Trials

   Published: 27/05/2022
5. Dating and Breast Cancer

   Published: 29/04/2022
6. Adolescent and Young Adult Breast Cancer

   Published: 28/03/2022
7. Top Research Presented at the 2021 San Antonio Breast Cancer Symposium

   Published: 21/12/2021
8. Aromatase Inhibitors versus Tamoxifen for Pre-Menopausal Women Diagnosed With Early-Stage, Hormone Receptor-Positive Disease

   Published: 13/12/2021
9. Experimental Elacestrant: A Standard of Care for Pre-Treated, Metastatic, Hormone Receptor-Positive, HER2-Negative Breast Cancer?

   Published: 11/12/2021
10. Alcohol and Breast Cancer Risk

    Published: 05/11/2021
11. Breast Cancer Research at ESMO 2021

    Published: 21/10/2021
12. Kisqali Plus Femara Seems Best Option for Advanced-Stage Hormone-Receptor-Positive HER2-Negative Breast Cancer

    Published: 01/10/2021
13. Keytruda Added to Chemotherapy Improves Overall Survival for Metastatic PD-L1-Positive, Triple-Negative Breast Cancer

    Published: 24/09/2021
14. The Importance of Diversity in Breast Cancer Clinical Trials

    Published: 15/09/2021
15. Tattoo Ink Showing Up on Mammograms

    Published: 20/08/2021
16. Immunotherapy Keytruda for Early-Stage Triple-Negative Breast Cancer: Better pCR and Lower Recurrence Rates: ESMO 2019 Coverage

    Published: 27/07/2021
17. Reconstruction Options After Lumpectomy

    Published: 16/07/2021
18. Breast Cancer Research at the 2021 ASCO Annual Meeting

    Published: 02/07/2021
19. Breast Cancer, a CEO, and a New Nonhormonal Birth Control

    Published: 29/06/2021
20. Breast Cancer Recurrence Risk

    Published: 11/06/2021